ScholarIQanswers from OpenAlex

Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study

PaperCitations, authors & open-access status

Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study have?

ScholarIQcitation count

Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study has 39 citations in the OpenAlex counts ScholarIQ stores.

When was Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study published?

ScholarIQyear

Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study has 2012 year in the ScholarIQ index.

What is the open-access status of Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study?

ScholarIQoa status

Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study has closed oa status in the ScholarIQ index.

What is the DOI of Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study?

ScholarIQdoi

The DOI for Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study is on the source record.

What is the PMID of Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study?

ScholarIQpmid

The PMID for Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study is on the source record.

What is the OpenAlex record for Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study?

ScholarIQopenalex

The OpenAlex for Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial